For the quarter ending 2026-03-31, INNV had $12,333K increase in cash & cash equivalents over the period. $14,537K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| (loss) gain on cost and equity method investments | - | - | - | -1,393 |
| Net loss | -29,940 | 11,805 | 7,669 | -35,343 |
| (gain) loss on disposal of assets | 104 | -109 | 483 | -508 |
| Provision for uncollectible accounts | 0 | 0 | 0 | 524 |
| Depreciation and amortization | 4,824 | 4,877 | 5,085 | 19,510 |
| Operating lease rentals | 1,525 | 1,516 | 1,562 | 6,361 |
| Loss on assets held for sale | - | - | 104 | - |
| Impairments and loss on assets held for sale | 0 | 104 | - | 13,615 |
| Amortization of deferred financing costs | 127 | 192 | 213 | 429 |
| Stock-based compensation | 1,790 | 1,216 | 2,308 | 7,619 |
| Deferred income taxes | 10 | 264 | 247 | 1,301 |
| Other, net | 636 | 805 | 598 | 1,714 |
| Accounts receivable | 7,282 | -1,872 | -13,199 | -11,210 |
| Prepaid expenses and other current assets | 771 | 5,489 | 1,306 | 4,041 |
| Income tax receivable | 77 | - | - | -14 |
| Deposits and other | 555 | 548 | 950 | 6,419 |
| Accounts payable and accrued expenses | 48,054 | 4,713 | -24,303 | 20,431 |
| Reported and estimated claims | -1,077 | 3,840 | -368 | 3,567 |
| Due to medicaid and medicare | 2,278 | -2,249 | 1,908 | -814 |
| Income taxes payable | - | - | - | 0 |
| Operating lease liabilities | -1,573 | -1,562 | -1,559 | -8,713 |
| Deferred revenue | 275 | - | - | 0 |
| Net cash provided by operating activities | 18,140 | 21,361 | 3,924 | 32,866 |
| Purchases of property and equipment | 3,603 | 2,363 | 4,077 | 6,263 |
| Purchases of short-term investments | 198 | 542 | 453 | 2,065 |
| Proceeds from sale of assets held for sale | 0 | 0 | 3,716 | - |
| Proceeds from sale of short-term investments | 0 | 0 | - | 6,300 |
| Proceeds from dissolution of equity method investments | - | - | - | 1,252 |
| Acquisition of business | 0 | - | - | 4,774 |
| Net cash used in investing activities | -3,801 | -2,905 | -814 | -5,550 |
| Payments for finance lease obligations | 1,288 | 1,319 | 1,395 | 6,107 |
| Principal payments on long-term debt | 634 | 634 | 60,012 | 3,799 |
| Proceeds from the issuance of long-term debt | 0 | 0 | 60,082 | - |
| Payments on financing costs | 0 | 422 | 1,567 | - |
| Repurchase of equity securities | 0 | 0 | 0 | -7,321 |
| Contribution from joint venture partner | 0 | 0 | 3,200 | 0 |
| Taxes paid related to net settlements of stock-based compensation awards | 84 | 25 | 319 | 1,855 |
| Net cash used in financing activities | -2,006 | -2,400 | -11 | -19,082 |
| Net change in cash, cash equivalents and restricted cash including cash reclassified to assets held for sale | 12,333 | 16,056 | 3,099 | 8,234 |
| Less change in cash and restricted cash reclassified to assets held for sale | 0 | 0 | -82 | -1,054 |
| Increase in cash, cash equivalents & restricted cash | 12,333 | 16,056 | 3,017 | 7,180 |
| Cash, cash equivalents & restricted cash, beginning of period | 83,213 | 67,157 | 64,140 | - |
| Cash, cash equivalents & restricted cash, end of period | 95,546 | 83,213 | 67,157 | - |
InnovAge Holding Corp. (INNV)
InnovAge Holding Corp. (INNV)